Naphazoline Hydrochloride

็›้…ธ่˜็”ฒๅ”‘ๅ•‰

Report date: 2023/02/21 20:00:25
NME

Base Information

Drug NameNaphazoline Hydrochloride
Drug Alias Name็›้…ธ่˜็”ฒๅ”‘ๆž—naphazoline็›้…ธ็บณๅ‘ๅ”‘ๅ•‰nafazolinanaphazolinum +[13]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha adrenergic receptor agonists
TargetsAlpha adrenergic receptor
Therapy Area/IndicationsConjunctivitisNasal ObstructionRhinitis
Global Approved IndicationsNasal ObstructionRhinitis
Approved Indications in ChinaNasal ObstructionRhinitis
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Medison Pharmaceutical Co LTDWuhan Wujing Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsConjunctivitisNasal ObstructionRhinitis
Inactive IndicationsN/A

Other Information

ATC CodeR01AA08R01AB02S01GA01
Related LinksWikipediaDrugBankKEGG